Letter. SSSFT staff can use the OVID link, or you can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
In Reply We thank Solanto for her interest in our article1 and for providing some thoughtful ideas on how to understand these intriguing similar findings from 3 population samples that challenge the notion of attention-deficit/hyperactivity disorder (ADHD) as only a child-onset neurodevelopmental disorder.2,3 Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
"Youngest children in class more likely to be labelled hyperactive," The Times reports. A Finnish study raises the possibility that some children may have been misdiagnosed with ADHD, when in fact their behaviour was age-appropriate.
There is a global trend of large increases in the prevalence and incidence of Attention Deficit Hyperactivity Disorder (ADHD). This study aimed to address potential causes of these major changes.
To examine in a community-based cohort: (1) the prevalence of chronic tic disorder (CTD) in children with attention-deficit/hyperactivity disorder (ADHD) compared with non-ADHD controls at ages 7 and 10; and (2) the additional psychiatric and functional burden of CTD in children with ADHD.. To read the full article, log in using your NHS OpenAthens details.
In 10 to 20 years we'll be able to pharmacologically turn sleep off. It's already being quelled with Modafinil, a stimulant with a near-mythical reputation for keeping you awake without the jitters, excessive euphoria, and eventual crash that come after
...a newly published study from the University of California at Berkeley focuses on girls with the condition, showing many of the same unfortunate results. Visible symptoms of hyperactivity and restlessness largely recede during adolescence, but the girls
Unlike conventional stimulants, no anxiety, agitation and insomnia; selectively stimulates brain's adrenergic receptors for norepinephrine (noradrenaline), a neurotransmitter linked to alertness, learning, and memory.
'As the review authors suggest, more research with well-designed trials is needed to better assess the benefits and harms of the treatment, preferably with some subgroup analyses to see if it is possible to identify those who might have better or worse outcomes.'
Research into the effect of a widely used medicine on ADHD symptoms urges clinicians to use caution when prescribing it. Login using your SSSFT NHS Athens for full text. SSOTP - request a copy of the article from the library http://www.sssft.nhs.uk/library
What this study adds The results suggest that among children and adolescents with a diagnosis of ADHD, methylphenidate may improve teacher reported symptoms of ADHD and general behaviour and parent reported quality of life. However, given the risk of bias in the included studies, and the very low quality of outcomes, the magnitude of the effects is uncertain. Methylphenidate is associated with an increased risk of non-serious but not serious adverse events